RxDoctor Payments Data

Vivian Nanagas, MD

Allergy & Immunology · Zionsville, INNPI 1285977033

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $231 of the $288 with a category attached, or 80.3%. It is spread thinly across 8 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for allergy & immunology clinicians in IN, where the typical reported total is $4,393.

$288in general payments, 2019–2025

Across 15 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$61
  • Welch Allyn$57
  • GSK$48
  • Pfizer$36
  • Sanofi$28
  • Amgen$26
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$23180%
  • Other$5720%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$288 in reported general payments places this provider in the 10th percentile of 49 allergy & immunology providers in Indiana.

See all allergy & immunology providers in Indiana

Medicare billing

Part B allowed, 2024
$246,635
Medicare patients
120
Services billed
8,739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab21$80,285
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$54,352
Breo ElliptaFluticasone/Vilanterol55$27,013
Spiriva RespimatTiotropium Bromide31$20,414
Epinephrine50$8,260
Incruse ElliptaUmeclidinium Bromide22$8,241
SymbicortBudesonide/Formoterol Fumarate20$7,488
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate57$7,181
Fluticasone-SalmeterolFluticasone Propion/Salmeterol47$6,129
Azelastine Hcl120$3,509
Wixela InhubFluticasone Propion/Salmeterol19$2,648
Albuterol Sulfate HfaAlbuterol Sulfate65$1,709
Fluticasone Propionate118$1,589
Montelukast Sodium158$1,300
Levalbuterol Tartrate HfaLevalbuterol Tartrate19$1,120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$48$89,607139 claims
AstraZenecaSymbicort$61$7,48820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 49 allergy & immunology providers in Indiana.

Other allergy & immunology in Zionsville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →